Cite
HARVARD Citation
Law, S. et al. (2017). Use of intravenous epoprostenol as a treatment for the digital vasculopathy associated with the scleroderma spectrum of diseases. Journal of scleroderma and related disorders. 2 (3), pp. 208-212. [Online].